Exploring different phenotypes of COPD

New England Journal of Medicine

Volumn 373, Issue 2, 2015, Pages 185-186

  Speizer, Frank E ^a   Ware, James H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ADULTHOOD; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DETERIORATION; DISEASE ACTIVITY; DISEASE SEVERITY; EDITORIAL; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GRADING SYSTEM; HEREDITY; HUMAN; ILLNESS TRAJECTORY; LONGITUDINAL STUDY; LUNG FUNCTION; OCCUPATIONAL EXPOSURE; PHENOTYPE; POLLUTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE ASSESSMENT; RISK FACTOR; SMOKING; SPIROMETRY; SURVIVAL; DISEASE COURSE; FEMALE; MALE; PATHOPHYSIOLOGY;

DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84936806217     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1503888     Document Type: Editorial

References (6)

1. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013; 61: 1-117.
2. Lange P, Celli B, Agust? A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015; 373: 111-22.
3. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996; 335: 931-7.
4. Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed - urgently. Am J Respir Crit Care Med 2010; 182: 863-4.
5. Duvoix A, Dickens J, Haq I, et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013; 68: 670-6.
6. Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap: clinical relevance of genomic signatures of type 2 inflammation in COPD. Am J Respir Crit Care Med 2015; 191: 758-66.